vrtx

Vertex Pharmaceuticals Earnings Review: 18 Days after Announcement Shares Up 3.5% (VRTX)

Published on Sat, 05/18/2013 - 09:25
By Robert Cotter in Earnings Lookback, vrtx, earnings flashbacks, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Robert Cotter
rcotter@fnno.com

Stock Investors Sell Off Shares of Vertex Pharmaceuticals, Down 1.8%

Published on Wed, 05/15/2013 - 10:23
By Peter Chu in Market movers, vrtx, market movers, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Peter Chu
pchu@fnno.com

Vertex Pharmaceuticals Shares Climbing Higher, Up 1.4%

Published on Thu, 05/09/2013 - 12:32
By Robert Cotter in Market movers, vrtx, market movers, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Robert Cotter
rcotter@fnno.com

Stock Investors Bid Up Shares of Vertex Pharmaceuticals, Up 2.3%

Published on Mon, 05/06/2013 - 12:24
By Mallory Stone in Market movers, vrtx, market movers, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Mallory Stone
mstone@fnno.com

Relatively Good Performance Detected in Shares of Regeneron Pharmaceuticals in the Biotechnology Industry (REGN, AMGN, VRTX, SNTA, ARNA)

REGN

By Peter Chu
pchu@fnno.com

Vertex Pharmaceuticals Crosses Above its 10-day MA (VRTX)

Published on Wed, 05/01/2013 - 11:12
By Robert Cotter in Moving average crossovers, vrtx, moving crosses, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Robert Cotter
rcotter@fnno.com

Shares of Vertex Pharmaceuticals Under Pressure, Down 1.8%

Published on Tue, 04/30/2013 - 12:45
By Robert Cotter in Market movers, vrtx, market movers, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Robert Cotter
rcotter@fnno.com

Vertex Pharmaceuticals Up 51.9% Since Canaccord Genuity Upgraded One Week Ago (VRTX)

Published on Fri, 04/26/2013 - 09:12
By Adrienne Chilton in Analyst reflections, vrtx, analyst reflections, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Adrienne Chilton
achilton@fnno.com

Vertex Pharmaceuticals In Retrospect: Shares Up 51.9% Since Upgraded One Week Ago (VRTX)

Published on Fri, 04/26/2013 - 09:11
By Adrienne Chilton in Analyst reflections, vrtx, analyst reflections, nasdaq:vrtx, vertex pharmaceuticals
VRTX

By Adrienne Chilton
achilton@fnno.com

Analysis of Relative Performance in the Biotechnology Industry for Shares of Exact Sciences (EXAS, VRTX, SNTA, ALXN, MDVN)

EXAS

By Mallory Stone
mstone@fnno.com

Latest News from FNNO

Earnings Look Back: Comcast Is Up 3.1% S...

When Comcast (NASDAQ:CMCSK) reported earnings 17 days ago on May 1st, 2013, analysts, o ...

Earnings Flashback: Since Reporting Quar...

A week ago on May 6th, 2013 Liberty Global (NASDAQ:LBTYA) reported earnings and analyst ...

Earnings Look Back: Kelly Services Is Up...

When Kelly Services (NASDAQ:KELYA) reported earnings a week ago on May 8th, 2013, analy ...

Liberty Media Earnings Review: 10 Days a...

When Liberty Media (NASDAQ:LINTA) reported earnings a week ago on May 8th, 2013, analys ...

Central Garden and Pet Earnings Hindsigh...

A week ago on May 8th, 2013 Central Garden and Pet (NASDAQ:CENTA) reported earnings and ...

Comcast Earnings Review: 17 Days after A...

When Comcast (NASDAQ:CMCSA) reported earnings 17 days ago on May 1st, 2013, analysts, o ...

Earnings Flashback: Since Reporting Quar...

A week ago on May 7th, 2013 Discovery Communications (NASDAQ:DISCA) reported earnings a ...

Jazz Pharmaceuticals Earnings In Retrosp...

11 days ago, on May 7th, 2013, Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its earnings ...

Most Popular Video News